Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Continuous Glucose Monitors Pipeline Market Report Overview

The continuous glucose monitoring system helps in the continuous measurement of blood glucose. The Continuous Glucose Monitors pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        The US

·        Europe

·        South Korea

·        Israel

·        China

Key Regulatory Paths ·        510(k)

·        CE

·        PMA

·        MDITAC

·        NMPA

Leading Companies ·        Abbott Diabetes Care Inc

·        Advanced Biosensors-Ohio LLC

·        Advanced Medical Electronics Corp

·        Apollon Inc

·        Arkal Medical Inc (Inactive)

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Continuous Glucose Monitors Pipeline Market Segmentation by Territories

A few of the key territories for Continuous Glucose Monitors pipeline products are the US, Europe, South Korea, Israel, and China. As of December 2023, the US accounted for the highest number of pipeline products.

Continuous Glucose Monitors Pipeline Market Analysis by Territories, 2023 (%)

Continuous Glucose Monitors Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Continuous Glucose Monitors Pipeline Market

Download a Free Report Sample

Continuous Glucose Monitors Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Continuous Glucose Monitors pipeline market are 510(k), CE, PMA, MDITAC, and NMPA. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

Continuous Glucose Monitors Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Continuous Glucose Monitors Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Continuous Glucose Monitors Pipeline Market

Download a Free Report Sample

Continuous Glucose Monitors Pipeline Market – Competitive Landscape

A few of the key companies associated with the Continuous Glucose Monitors pipeline market are Abbott Diabetes Care Inc., Advanced Biosensors-Ohio LLC, Advanced Medical Electronics Corp, Apollon Inc., and Arkal Medical Inc. (Inactive), among others.

Abbott Diabetes Care Inc.: Abbott Diabetes Care Inc. is headquartered in Alameda, California, the US. The company has a presence in the US, the Americas, Africa, Asia Pacific, and the Middle East. It is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use as well as hospital use.

Advanced Medical Electronics Corp (AME): AME is headquartered in Maple Grove, Minnesota, the US. It is a medical device company that provides research and development services. The company also has partnerships with universities, healthcare agencies, and cancer institutes, among others. Its products include electrocardiographs, spirometer equipment, battery-powered surgical headlamps, and wrist-worn pulse oximeters, among others.

Continuous Glucose Monitors Pipeline Market Analysis by Companies, 2023

Continuous Glucose Monitors Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Continuous Glucose Monitors Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Continuous Glucose Monitors Pipeline Market Territories Outlook

  • The US
  • Europe
  • South Korea
  • Israel
  • China

Continuous Glucose Monitors Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • PMA
  • MDITAC
  • NMPA

Scope

This report provides:

  • Extensive coverage of the Continuous Glucose Monitors under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Continuous Glucose Monitors and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Continuous Glucose Monitors under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Abbott Diabetes Care Inc
Advanced Biosensors-Ohio LLC
Advanced Medical Electronics Corp
Apollon Inc
Arkal Medical Inc (Inactive)
Azurite Technologies, Inc. (Inactive)
Biovotion AG
CALISTO MEDICAL, INC. (Inactive)
CGM3 Ltd
City, University of London
Columbia University
ConvaTec Group Plc
Cyber Medical Ltd (Inactive)
DexCom Inc
Echo Therapeutics Inc
eLutions Integrated Systems, Inc.
Flowsion A/S
Gili Medical Ltd
Globe Medical Tech Inc (Inactive)
GlucoLight Corporation (Inactive)
Glucometrix AG
Glucosense Diagnostics Ltd (Inactive)
GlucoTrack Inc
GluMetrics Inc
Glusense Ltd
GlySens Inc
Guided Therapeutics Inc
Hagar Tech
iGlyko, Inc. (Inactive)
Innovosens AB
Invivosense ASA (Inactive)
I-Sens Inc
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Know Labs Inc
KTH Royal Institute of Technology
LEMM Technologies, LLC
Medical Wireless Sensing Ltd
Medtronic MiniMed Inc
Metronom Health Inc
MicroTech Medical Co Ltd
mobiLIFE
Nemaura Medical Inc
Newton Photonics Inc
Northwestern University
PKvitality SAS
Purdue University
SD Biosensor Inc
SensiVida Medical Technologies, Inc. (Inactive)
Socrates Health Solutions, Inc.
Stony Brook University
Swansea University
Tandem Diabetes Care Inc
Tenax Therapeutics Inc
Texas A&M University
Ultradian Diagnostics LLC
University of California Berkeley
University of California Irvine
University of California San Diego
University of South Carolina
University of South Florida
University of Technology Sydney
University of Texas at Arlington
Uxn Co Ltd
VeriTeQ Corporation

Table of Contents

1 Table of Contents 3

1.1 List of Tables 8

1.2 List of Figures 13

2 Introduction 14

2.1 Continuous Glucose Monitors Overview 14

3 Products under Development 15

3.1 Continuous Glucose Monitors – Pipeline Products by Stage of Development 15

3.2 Continuous Glucose Monitors – Pipeline Products by Territory 16

3.3 Continuous Glucose Monitors – Pipeline Products by Regulatory Path 17

3.4 Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 18

3.5 Continuous Glucose Monitors – Ongoing Clinical Trials 19

4 Continuous Glucose Monitors – Pipeline Products under Development by Companies 20

4.1 Continuous Glucose Monitors Companies – Pipeline Products by Stage of Development 20

4.2 Continuous Glucose Monitors – Pipeline Products by Stage of Development 23

5 Continuous Glucose Monitors Companies and Product Overview 25

5.1 Abbott Diabetes Care Inc Company Overview 25

5.1.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.2 Advanced Biosensors-Ohio LLC Company Overview 26

5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 26

5.3 Advanced Medical Electronics Corp Company Overview 27

5.3.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Apollon Inc Company Overview 28

5.4.1 Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Arkal Medical Inc (Inactive) Company Overview 29

5.5.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 Azurite Technologies, Inc. (Inactive) Company Overview 30

5.6.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

5.7 Biovotion AG Company Overview 31

5.7.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 CALISTO MEDICAL, INC. (Inactive) Company Overview 32

5.8.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 CGM3 Ltd Company Overview 33

5.9.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 City, University of London Company Overview 34

5.10.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Columbia University Company Overview 35

5.11.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 ConvaTec Group Plc Company Overview 36

5.12.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 Cyber Medical Ltd (Inactive) Company Overview 37

5.13.1 Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 DexCom Inc Company Overview 38

5.14.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Echo Therapeutics Inc Company Overview 40

5.15.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 eLutions Integrated Systems, Inc. Company Overview 43

5.16.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 Flowsion A/S Company Overview 44

5.17.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 Gili Medical Ltd Company Overview 45

5.18.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 Globe Medical Tech Inc (Inactive) Company Overview 46

5.19.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 GlucoLight Corporation (Inactive) Company Overview 47

5.20.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47

5.21 Glucometrix AG Company Overview 48

5.21.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 48

5.22 Glucosense Diagnostics Ltd (Inactive) Company Overview 49

5.22.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49

5.23 GlucoTrack Inc Company Overview 50

5.23.1 GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.24 GluMetrics Inc Company Overview 51

5.24.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.25 Glusense Ltd Company Overview 52

5.25.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.26 GlySens Inc Company Overview 53

5.26.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.27 Guided Therapeutics Inc Company Overview 54

5.27.1 Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.28 Hagar Tech Company Overview 55

5.28.1 Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 55

5.29 iGlyko, Inc. (Inactive) Company Overview 59

5.29.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59

5.30 Innovosens AB Company Overview 60

5.30.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 60

5.31 Invivosense ASA (Inactive) Company Overview 61

5.31.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61

5.32 I-Sens Inc Company Overview 62

5.32.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.33 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Company Overview 64

5.33.1 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.34 Know Labs Inc Company Overview 65

5.34.1 Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.35 KTH Royal Institute of Technology Company Overview 66

5.35.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 66

5.36 LEMM Technologies, LLC Company Overview 67

5.36.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 67

5.37 Medical Wireless Sensing Ltd Company Overview 68

5.37.1 Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview 68

5.38 Medtronic MiniMed Inc Company Overview 69

5.38.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.39 Metronom Health Inc Company Overview 70

5.39.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.40 MicroTech Medical Co Ltd Company Overview 71

5.40.1 MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

5.41 mobiLIFE Company Overview 72

5.41.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 72

5.42 Nemaura Medical Inc Company Overview 73

5.42.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.43 Newton Photonics Inc Company Overview 77

5.43.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.44 Northwestern University Company Overview 78

5.44.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 78

5.45 PKvitality SAS Company Overview 79

5.45.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 79

5.46 Purdue University Company Overview 82

5.46.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 82

5.47 SD Biosensor Inc Company Overview 83

5.47.1 SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.48 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 85

5.48.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 85

5.49 Socrates Health Solutions, Inc. Company Overview 86

5.49.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

5.50 Stony Brook University Company Overview 87

5.50.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 87

5.51 Swansea University Company Overview 88

5.51.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 88

5.52 Tandem Diabetes Care Inc Company Overview 90

5.52.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.53 Tenax Therapeutics Inc Company Overview 91

5.53.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.54 Texas A&M University Company Overview 92

5.54.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 92

5.55 Ultradian Diagnostics LLC Company Overview 93

5.55.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 93

5.56 University of California Berkeley Company Overview 94

5.56.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 94

5.57 University of California Irvine Company Overview 95

5.57.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 95

5.58 University of California San Diego Company Overview 96

5.58.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 96

5.59 University of South Carolina Company Overview 97

5.59.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 97

5.60 University of South Florida Company Overview 98

5.60.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 98

5.61 University of Technology Sydney Company Overview 99

5.61.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 99

5.62 University of Texas at Arlington Company Overview 100

5.62.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 100

5.63 Uxn Co Ltd Company Overview 101

5.63.1 Uxn Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.64 VeriTeQ Corporation Company Overview 104

5.64.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 104

6 Continuous Glucose Monitors- Recent Developments 105

6.1 Nov 13, 2023: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update 105

6.2 Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023 105

6.3 Oct 23, 2023: Invitation to Senzime’s Third Quarter 2023 Report Presentation 105

6.4 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023 106

6.5 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 106

6.6 Oct 10, 2023: Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023 108

6.7 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 108

6.8 Oct 03, 2023: Insulet Announces CFO Transition 109

6.9 Sep 26, 2023: Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence 109

6.10 Sep 19, 2023: Lifecare – Sanofi Product Development Agreement Update 110

6.11 Sep 11, 2023: Nemaura Medical Completes 100 Patient Study for Sugarbeat 24-Hour Wear and Reports Interim Results 110

6.12 Sep 05, 2023: Henry Schein to Present at Investor Conferences in September 2023 110

6.13 Aug 31, 2023: Glucotrack Announces the Appointment of Erin Carter to Board of Directors 111

6.14 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference 111

6.15 Aug 28, 2023: Glucotrack Announces Appointment of Drinda Benjamin as New VP of Marketing 111

6.16 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 112

6.17 Aug 18, 2023: Nemaura receives SFDA approval for wearable glucose sensor 112

6.18 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 113

6.19 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 113

6.20 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 113

6.21 Jul 14, 2023: Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023 114

6.22 Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023 114

6.23 Jun 21, 2023: Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System 115

6.24 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 115

6.25 Jun 07, 2023: Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring 115

6.26 May 30, 2023: Know Labs’ Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy 116

6.27 May 26, 2023: Daewoong’s cumulative CGM sales exceed 600,000 units 117

6.28 May 17, 2023: Lee’s Pharmaceutical Holdings Announces Poll Result of Annual General Meeting; Resignation & Appointment of an Independent Non-executive Director 117

6.29 May 16, 2023: Senzime Announces Bulletin from annual general meeting 118

6.30 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023 120

6.31 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 120

6.32 May 10, 2023: Dexcom showcases accuracy, reliability and ease of use of its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society 120

6.33 May 08, 2023: Know Labs reports data from feasibility study of Bio-RFID sensor 121

6.34 May 05, 2023: Senzime’s Nomination Committee Adjusts Its Proposal for Resolutions at the Annual General Meeting 122

6.35 Apr 27, 2023: Dexcom G6 Real-Time CGM System now accessible to any eligible client managing diabetes with insulin through NIHB 123

6.36 Apr 21, 2023: Invitation to Senzime’s first quarter 2023 report presentation 124

6.37 Apr 12, 2023: Medtronic has a layoff in California 124

6.38 Apr 10, 2023: Draper Names Sarah Leeper Vice President and General Manager for Electronic Systems 124

6.39 Mar 22, 2023: HAGAR announces preliminary results of study for its non invasive glucose monitoring system 124

6.40 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting 125

6.41 Mar 21, 2023: Manitoba becomes a provincial trailblazer in providing simplified Access to advanced glucose monitors 126

6.42 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 127

6.43 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022 127

6.44 Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year 129

6.45 Feb 22, 2023: Dexcom showcases accuracy, simplicity and connectivity of its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally 132

6.46 Feb 21, 2023: Ascensia Diabetes Care collaborates with SNAQ to support mealtime decision-making for people with diabetes 133

6.47 Feb 21, 2023: Dexcom G6 Continuous Glucose Monitoring System launches in Singapore 134

6.48 Feb 16, 2023: Henry Schein Reports Fourth-Quarter and Full-Year 2022 Financial Results and Introduces 2023 Financial Guidance 135

6.49 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023 137

6.50 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022 137

6.51 Feb 02, 2023: Mednow launches new Virtual Diabetes Management Program in partnership with Dexcom 138

6.52 Feb 01, 2023: Senzime Announces Interim report January-December 2022 139

6.53 Jan 26, 2023: Senzime’s Announces Invitation to fourth quarter 2022 report presentation 141

6.54 Jan 23, 2023: Senzime Notice of Extraordinary General Meeting 141

6.55 Jan 19, 2023: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 143

6.56 Jan 18, 2023: DexCom obtains additional 510(k) clearance for Dexcom G6 Continuous Glucose Monitoring System 143

6.57 Jan 17, 2023: Dexcom G6 Real-Time CGM System now available to all clients with type 1 diabetes covered under the non-insured health benefits program 144

6.58 Jan 12, 2023: Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 144

6.59 Dec 12, 2022: Dexcom Canada partners with Green Shield and The Health Depot to offer plan members a comprehensive digital diabetes care experience 145

6.60 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 146

6.61 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 146

7 Appendix 148

7.1 Methodology 148

7.2 About GlobalData 151

7.3 Contact Us 151

7.4 Disclaimer 151

Table

Continuous Glucose Monitors – Pipeline Products by Stage of Development 15

Continuous Glucose Monitors – Pipeline Products by Territory 16

Continuous Glucose Monitors – Pipeline Products by Regulatory Path 17

Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 18

Continuous Glucose Monitors – Ongoing Clinical Trials 19

Continuous Glucose Monitors Companies – Pipeline Products by Stage of Development 20

Continuous Glucose Monitors – Pipeline Products by Stage of Development 23

Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 25

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Status 25

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Description 25

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 26

My Medibit – Product Status 26

My Medibit – Product Description 26

Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Continuous Glucose Monitor – Product Status 27

Continuous Glucose Monitor – Product Description 27

Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Raman Spectroscopy – Non-Invasive Continuous Glucose Monitor – Product Status 28

Raman Spectroscopy – Non-Invasive Continuous Glucose Monitor – Product Description 28

Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

GlucoPod CGM System – Product Status 29

GlucoPod CGM System – Product Description 29

Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

Blood Glucose Sensor – Product Status 30

Blood Glucose Sensor – Product Description 30

Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 31

VSM 3 Glucose Monitoring System – Product Status 31

VSM 3 Glucose Monitoring System – Product Description 31

CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32

Glucoband – Product Status 32

Glucoband – Product Description 32

CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Miniaturized Implantable Continuous Glucose Monitor – Product Status 33

Miniaturized Implantable Continuous Glucose Monitor – Product Description 33

City, University of London Pipeline Products & Ongoing Clinical Trials Overview 34

Non-Invasive Glucose Monitor – Product Status 34

Non-Invasive Glucose Monitor – Product Description 34

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 35

Wearable Continuous Blood Glucose Monitoring Device – Product Status 35

Wearable Continuous Blood Glucose Monitoring Device – Product Description 35

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 36

Closed Loop Continuous Glucose Monitoring System – Product Status 36

Closed Loop Continuous Glucose Monitoring System – Product Description 36

Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37

Cybersensors Continuous Glucose Sensor – Product Status 37

Cybersensors Continuous Glucose Sensor – Product Description 37

DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 38

DexCom CGM With Accu-Chek Insulin Delivery System – Product Status 38

DexCom CGM With Accu-Chek Insulin Delivery System – Product Description 39

First-Gen Verily Sensor – Product Status 39

First-Gen Verily Sensor – Product Description 39

Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Display – Continuous Glucose Monitoring – Product Status 40

Display – Continuous Glucose Monitoring – Product Description 40

Gen 2 Symphony CGM System – Product Status 41

Gen 2 Symphony CGM System – Product Description 41

Symphony tCGM System – Home – Product Status 41

Symphony tCGM System – Home – Product Description 42

Symphony tCGM System – Hospital Critical Care – Product Status 42

Symphony tCGM System – Hospital Critical Care – Product Description 42

eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

Optically-Efficient Miniaturized Raman Optical System – Product Status 43

Optically-Efficient Miniaturized Raman Optical System – Product Description 43

Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 44

Glycostat – Product Status 44

Glycostat – Product Description 44

Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Diawatch – Product Status 45

Diawatch – Product Description 45

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

Continuous Glucose Monitoring Device – Product Status 46

Continuous Glucose Monitoring Device – Product Description 46

GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47

SENTRIS-100 – Product Status 47

SENTRIS-100 – Product Description 47

Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 48

Non-Invasive Blood Glucose Monitoring Device – Product Status 48

Non-Invasive Blood Glucose Monitoring Device – Product Description 48

Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49

Non-Invasive Blood Glucose Monitor – Product Status 49

Non-Invasive Blood Glucose Monitor – Product Description 49

GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 50

GlucoTrack – DF-C – Product Status 50

GlucoTrack – DF-C – Product Description 50

GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 51

GluCath Intravascular Continuous Glucose Monitor – Product Status 51

GluCath Intravascular Continuous Glucose Monitor – Product Description 51

Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Glyde CGM – Product Status 52

Glyde CGM – Product Description 52

GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Eclipse ICGM System – Product Status 53

Eclipse ICGM System – Product Description 53

Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Altea MicroPor Laser – Product Status 54

Altea MicroPor Laser – Product Description 54

Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 55

GWave – Product Status 55

GWave – Product Description 55

GWave 2.0 – Product Status 56

GWave 2.0 – Product Description 56

Hagar Tech – Ongoing Clinical Trials Overview 57

GWave – Study to Evaluate the Accuracy of GWave in Patients with Type 1 and Type 2 diabetes in Israel 58

iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59

iGlyko System – Product Status 59

iGlyko System – Product Description 59

Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 60

Diabetic Sensor – Continuous Glucose Monitoring – Product Status 60

Diabetic Sensor – Continuous Glucose Monitoring – Product Description 60

Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61

IvSCGM Biosensor – Product Status 61

IvSCGM Biosensor – Product Description 61

I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 62

CareSens Air Glucose Monitoring System – Product Status 62

CareSens Air Glucose Monitoring System – Product Description 62

Continuous Blood Glucose Meter – Product Status 63

Continuous Blood Glucose Meter – Product Description 63

Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Second-Generation CGM System – Product Status 64

Second-Generation CGM System – Product Description 64

Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 65

UBAND – Product Status 65

UBAND – Product Description 65

KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 66

Microneedle Patch – Glucose Monitoring – Product Status 66

Microneedle Patch – Glucose Monitoring – Product Description 66

LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 67

Non-Invasive Blood Glucose Monitor – Product Status 67

Non-Invasive Blood Glucose Monitor – Product Description 67

Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview 68

GlucoWiSe – Product Status 68

GlucoWiSe – Product Description 68

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 69

iPro 3 Glucose Monitoring System – Product Status 69

iPro 3 Glucose Monitoring System – Product Description 69

Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 70

CGM System – Product Status 70

CGM System – Product Description 70

MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71

AiDex X – Product Status 71

AiDex X – Product Description 71

mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 72

GlucoReader – Product Status 72

GlucoReader – Product Description 72

Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 73

sugarBEAT – Product Status 73

sugarBEAT – Product Description 74

Nemaura Medical Inc – Ongoing Clinical Trials Overview 75

sugarBEAT – Study is to Compare the sugarBEAT and Major Continuous Glucose Monitor Sensor in People with Diabetes 76

Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Non-invasive Blood Glucose Monitor – Product Status 77

Non-invasive Blood Glucose Monitor – Product Description 77

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 78

Continuous Glucose Sensor – Product Status 78

Continuous Glucose Sensor – Product Description 78

PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 79

K’Watch Glucose – Product Status 79

K’Watch Glucose – Product Description 79

PKvitality SAS – Ongoing Clinical Trials Overview 80

K’Watch Glucose – Clinical Investigation of K’Watch – Lab & Home Study 81

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 82

Soft Contact Lens – Product Status 82

Soft Contact Lens – Product Description 82

SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 83

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Status 83

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Description 83

Continuous Glucose Monitoring System – Product Status 84

Continuous Glucose Monitoring System – Product Description 84

SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 85

Glucose Monitoring System – Product Status 85

Glucose Monitoring System – Product Description 85

Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

Companion CM – Product Status 86

Companion CM – Product Description 86

Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 87

GlucoREAD Patch – Product Status 87

GlucoREAD Patch – Product Description 87

Swansea University Pipeline Products & Ongoing Clinical Trials Overview 88

Flash Glucose Monitoring Device – Product Status 88

Flash Glucose Monitoring Device – Product Description 88

Hi-Tech Diabetes Blood Glucose Monitor – Product Status 89

Hi-Tech Diabetes Blood Glucose Monitor – Product Description 89

Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 90

Next Generation Closed Loop – Product Status 90

Next Generation Closed Loop – Product Description 90

Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 91

Glucose Biosensor – Product Status 91

Glucose Biosensor – Product Description 91

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 92

Minimally Invasive Glucose Monitoring System – Product Status 92

Minimally Invasive Glucose Monitoring System – Product Description 92

Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 93

Biologue – Product Status 93

Biologue – Product Description 93

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 94

Dropsense Continuous Glucose Monitor – Product Status 94

Dropsense Continuous Glucose Monitor – Product Description 94

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 95

Implantable Device – Diabetes Mellitus – Product Status 95

Implantable Device – Diabetes Mellitus – Product Description 95

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 96

Glucose Monitoring Tattoo – Product Status 96

Glucose Monitoring Tattoo – Product Description 96

University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 97

Continuous Glucose Monitoring System – Product Status 97

Continuous Glucose Monitoring System – Product Description 97

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 98

Long Term Silicon Carbide (SiC) RF Antenna – Product Status 98

Long Term Silicon Carbide (SiC) RF Antenna – Product Description 98

University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 99

Hypo Detection System – Product Status 99

Hypo Detection System – Product Description 99

University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 100

Nanotechnology Based Glucose Monitoring Device – Product Status 100

Nanotechnology Based Glucose Monitoring Device – Product Description 100

Uxn Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

Always Glucose Monitoring System (AGMS) – Product Status 101

Always Glucose Monitoring System (AGMS) – Product Description 101

Continuous Blood Glucose Meter – Product Status 102

Continuous Blood Glucose Meter – Product Description 102

Implantable Continuous Blood Glucose Meter – Product Status 102

Implantable Continuous Blood Glucose Meter – Product Description 103

Microneedle Continuous Blood Glucose Meter – Product Status 103

Microneedle Continuous Blood Glucose Meter – Product Description 103

VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 104

GlucoChip – Product Status 104

GlucoChip – Product Description 104

Glossary 150

Figures

Continuous Glucose Monitors – Pipeline Products by Stage of Development 14_x000D_

Continuous Glucose Monitors – Pipeline Products by Territory 15_x000D_

Continuous Glucose Monitors – Pipeline Products by Regulatory Path 16_x000D_

Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 17_x000D_

Continuous Glucose Monitors – Ongoing Clinical Trials 18_x000D_

Frequently asked questions

Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.